Dr Reddy's Aims to Launch Generic Wegovy at 60% Discount
Dr Reddy's Laboratories plans to launch a generic version of Novo Nordisk's Wegovy at 60% below the branded price, pending regulatory approval. The company recently received approval for generic Ozempic.
Indian drugmaker Dr Reddy's Laboratories aims to launch a generic version of Novo Nordisk's blockbuster weight loss drug Wegovy, subject to approval, at a price about 60% lower than the branded version, the co-chairman and managing director told reporters on Tuesday.
The company last month received an approval from India's drug regulator to manufacture and sell the generic version of blockbuster diabetes drug Ozempic and said it was awaiting approval for Wegovy.